Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Clinical significance of cathepsin D concentration demystified
September 1st, 2005
Researchers revealed the clinical significance of cathepsin D concentration in the tumor cytosol of primary breast cancer. "Cathepsin D is the proteolytic enzyme most frequently implicated as a prognostic factor in primary breast cancer. In the present study we evaluated by means of an immunoradiometric assay the tumor content of this protease in primary breast cancer, its relationship with tumor-related clinical and pathological parameters, and its prognostic significance in a large series of breast cancer patients. The study comprised 1033 women with histologically established invasive breast cancer," scientists in Spain reported. "Cathepsin D was...
Source: Women's Health Weekly (2005-09-01)
|
